|
Market Closed -
Nasdaq
01:30:00 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.870 USD | -0.17% |
|
-23.14% | -23.34% |
| Market Cap | 15Cr 13Cr 12Cr 11Cr 21Cr 1.4TCr 21Cr 146.13Cr 58Cr 732.25Cr 55Cr 54Cr 2.32TCr | P/E 2026 * |
-1.08x | P/E 2027 * | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 15Cr 13Cr 12Cr 11Cr 21Cr 1.4TCr 21Cr 146.13Cr 58Cr 732.25Cr 55Cr 54Cr 2.32TCr | EV / Sales 2026 * |
2.85x | EV / Sales 2027 * | 4.65x |
| Free-Float |
97.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| STRO | Delayed | |
CBOE
| STRO | Real-time | |
|
Deutsche Boerse AG
| S090 | Delayed | |
|
Tradegate
| S090 | Real-time | |
|
Boerse Muenchen
| S090 | Real-time |
Last Transcript: Sutro Biopharma, Inc.
| 17/24/17 | Indizes: Klein aber fein | |
| 17/24/17 | Indexen: klein is weer fijn | |
| 16/24/16 | Indici: ciò che è piccolo torna in auge | |
| 16/24/16 | Índices: Lo pequeño vuelve a ser bonito | |
| 16/24/16 | Indices : Ce qui est petit redevient mignon |
| 1 day | -0.17% | ||
| 1 week | -23.14% | ||
| Current month | -44.94% | ||
| 1 month | -44.49% | ||
| 3 months | -63.06% | ||
| 6 months | -73.59% | ||
| Current year | -23.34% |
| 1 week | 8.11 |  | 10.93 |
| 1 month | 8.11 | | 16.66 |
| Current year | 8.11 | | 43.85 |
| 1 year | 7.15 | | 43.85 |
| 3 years | 5.23 | | 61.3 |
| 5 years | 5.23 | | 237 |
| 10 years | 5.23 | | 283 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jane Chung
CEO | Chief Executive Officer | 55 | 13/03/2025 |
Gregory Chow
DFI | Director of Finance/CFO | 53 | 02/06/2025 |
Devendra Luhar
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Petree
BRD | Director/Board Member | 70 | 01/08/2009 |
Joseph Lobacki
BRD | Director/Board Member | 67 | 01/02/2017 |
Michael Dybbs
BRD | Director/Board Member | 51 | 25/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/09/26 | Exercice | Chief Technology Officer | 8,845 | 0.0533% | ||
| 02/06/26 | Exercice | Chief Financial Officer | 5,000 | 0.0302% | ||
| 04/03/26 | Exercice | Chief Administrative Officer | 1,627 | 0.0099% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | -23.14% | -23.53% | -65.35% | 15Cr | |
| -3.10% | -4.19% | +32.67% | +59.47% | 6.53TCr | |
| +0.33% | +0.33% | +10.16% | +78.07% | 5.46TCr | |
| +0.16% | +1.73% | +9.89% | +102.10% | 5.36TCr | |
| -0.75% | +1.38% | +24.89% | +50.91% | 4.5TCr | |
| -1.30% | -4.80% | +16.05% | +114.76% | 4.22TCr | |
| +1.26% | -5.26% | +221.12% | +900.64% | 3.94TCr | |
| -0.74% | -4.46% | +11.00% | +44.65% | 3.27TCr | |
| +1.11% | +15.18% | +60.27% | +49.33% | 2.65TCr | |
| +3.58% | -6.68% | +25.41% | -8.71% | 2.4TCr | |
| Average | +0.00% | -2.47% | +38.79% | +132.59% | 3.83TCr | |
| Weighted average by Cap. | -0.34% | -0.59% | +42.50% | +153.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.16Cr 4.63Cr 4.27Cr 3.87Cr 7.24Cr 489.66Cr 7.33Cr 51Cr 20Cr 256.66Cr 19Cr 19Cr 813.9Cr | 3.16Cr 2.84Cr 2.62Cr 2.37Cr 4.44Cr 300.11Cr 4.49Cr 31Cr 12Cr 157.3Cr 12Cr 12Cr 498.83Cr |
| Net income | -13Cr -12Cr -11Cr -9.73Cr -18Cr -1.23TCr -18Cr -128.68Cr -51Cr -644.83Cr -49Cr -48Cr -2.04TCr | -14Cr -13Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -139.83Cr -56Cr -700.68Cr -53Cr -52Cr -2.22TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $8.870 | -0.17% | 4,53,236 |
| 26/26/26 | $8.885 | -4.77% | 6,94,466 |
| 23/26/23 | $9.330 | -9.33% | 4,30,837 |
| 22/26/22 | $10.29 | -4.63% | 2,93,292 |
| 21/26/21 | $10.79 | -6.50% | 4,39,854 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- STRO Stock
Select your edition
All financial news and data tailored to specific country editions
